Cargando…
Intracranial delivery of synthetic mRNA to suppress glioblastoma
Owing to messenger RNA's unique biological advantages, it has received increasing attention to be used as a therapeutic, known as mRNA-based gene therapy. It is critical to have an ideal strategy of mRNA gene therapy for glioma, which grows in a special environment. In the present study, we scr...
Autores principales: | Peng, Hao, Guo, Xingrong, He, Jinjuan, Duan, Chao, Yang, Minghuan, Zhang, Xianghua, Zhang, Li, Fu, Rui, Wang, Bin, Wang, Dekang, Chen, Hu, Xie, Mengying, Feng, Ping, Dai, Longjun, Tang, Xiangjun, Luo, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724946/ https://www.ncbi.nlm.nih.gov/pubmed/35024442 http://dx.doi.org/10.1016/j.omto.2021.12.010 |
Ejemplares similares
-
Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy
por: Tang, Xiangjun, et al.
Publicado: (2022) -
Therapeutic Prospects of mRNA-Based Gene Therapy for Glioblastoma
por: Tang, Xiangjun, et al.
Publicado: (2019) -
Prognostic and Predictive Value of an Immunoscore Signature in Glioblastoma Multiform
por: Tang, Xiangjun, et al.
Publicado: (2020) -
Identification of a Specific Gene Module for Predicting Prognosis in Glioblastoma Patients
por: Tang, Xiangjun, et al.
Publicado: (2019) -
Case Report: Primary Pulmonary Angiosarcoma With Brain Metastasis
por: Tang, Xiangjun, et al.
Publicado: (2022)